Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Competing interests: CV and FDM have nothing to disclose.
Competing interests: RP is the Vice President, Worldwide FOT and Asthma Management Business Development, MGC Diagnostics International.
Competing interests: RLD reports grants from Restech, personal fees from Philips Healthcare, outside the submitted work; In addition, Dr Dellaca' has a patent on the detection of EFL by FOT with royalties paid to Philips Respironics and Restech Srl, a patent on monitoring lung volume recruitment by FOT with royalties paid to Vyaire, and a patent on early detection of exacerbations by home monitoring of FOT with royalties paid to Restech and is co-founder and shareholder of Restech Srl, a spin-off company of the Politecnico di Milano University producing medical devices for lung function testing based on FOT.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received August 31, 2022.
- Accepted January 16, 2023.
- Copyright ©The authors 2023
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org
